Becton Dickinson and Company (BDX) stock news · P/E 34, rev $21.84B
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
This BDX news page leads with what Becton Dickinson and Company filed — not a scraped headline mill.
No cached 8-K sentence for BDX yet. We will not pad this page with generic market recap.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BDX stock page; for the tape open the quote page.
Not investment advice.